Cannim’s Lumir flower product is the second medical cannabis product to gain access to the European medical marijuana industry. Both products are being managed through the Fast track access platform. This platform currently boasts of over 14 cultivars from all over the world since its launch in June. With Cantourage managing the flower’s value chain, cannim will be able to get into the European market in no time.
Germany has received nearly 900 applications for cannabis cultivation associations, but only just over half…
A Senate stopgap funding bill would delay the federal prohibition on most hemp-derived THC products…
He smokes in boardrooms, but he’s still on that underground frequency. This content originally appeared…
Fox News opinion ran a piece recently from Scott Chipman, vice president of Americans Against…
For our 50th anniversary, we handed the plant to the artists making its most striking…
Corporate valuation increased in 21 of the 38 states studied following medical marijuana legalization. Gross…